Premium
The Arg617–Arg618 cleavage site in the C‐terminal domain of PC1 plays a major role in the processing and targeting of the enzyme within the regulated secretory pathway
Author(s) -
Bernard Natacha,
Kitabgi Patrick,
RovereJovene Carole
Publication year - 2003
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.2003.01823.x
Subject(s) - secretory pathway , secretion , prohormone convertase , secretory protein , mutant , microbiology and biotechnology , biology , intracellular , enzyme , secretory vesicle , cleavage (geology) , biochemistry , endoplasmic reticulum , golgi apparatus , prohormone , hormone , gene , paleontology , exocytosis , fracture (geology)
The C‐terminal domain of the prohormone convertase PC1 is involved in targeting of the enzyme to secretory granules in neuroendocrine cells and is subsequently processed in this compartment at an Arg617‐Arg618 site. Three other dibasics are found in the C‐terminal domain of mouse PC1. Here, we examined the role of the four dibasics in targeting PC1 to secretory granules. All 15 possible combinations of dibasic mutations were performed. Wild‐type (WT) and mutant PC1 were stably expressed in neuroendocrine PC12 cells that lacked endogenous PC1. Processing, secretion and intracellular localization of PC1 and its mutants were analyzed. Leaving intact Arg617‐Arg618 and mutating any combination of the three other dibasics yielded proteins that were stored and processed in secretory granules, similarly to WT PC1. Mutating Arg617‐Arg618 alone or with any one of the three remaining dibasics generated proteins that were efficiently stored in secretory granules but were not processed further. Mutating Arg617‐Arg618 with more than one of the remaining dibasics produced proteins that reached the TGN but were not stored in secretory granules and exited the cells through the constitutive secretory pathway. These data demonstrate that the Arg617‐Arg618 plays a prominent role in targeting PC1 to secretory granules.